TRPC4 inactivation confers a survival benefit in severe pulmonary arterial hypertension.
about
Transmembrane proteoglycans control stretch-activated channels to set cytosolic calcium levels.The cancer theory of pulmonary arterial hypertension.The Role of Transient Receptor Potential Channel 6 Channels in the Pulmonary VasculatureMolecular and clinical analysis of TRPC6 and AGTR1 genes in patients with pulmonary arterial hypertension.Upregulation of Transient Receptor Potential Canonical Channels Contributes to Endotoxin-Induced Pulmonary Arterial Stenosis.Temporal hemodynamic and histological progression in Sugen5416/hypoxia/normoxia-exposed pulmonary arterial hypertensive rats.NADPH oxidases-do they play a role in TRPC regulation under hypoxia?Transient Receptor Potential Channel 4 Encodes a Vascular Permeability Defect and High-Frequency Ca(2+) Transients in Severe Pulmonary Arterial Hypertension.Endothelial hyperpermeability in severe pulmonary arterial hypertension: role of store-operated calcium entry.Endothelial Cell Reactive Oxygen Species and Ca2+ Signaling in Pulmonary Hypertension.Marked Strain-Specific Differences in the SU5416 Rat Model of Severe Pulmonary Arterial Hypertension.Pulmonary vascular dysfunction secondary to pulmonary arterial hypertension: Insights gained through retrograde perfusion.Impaired Pulmonary Arterial Vasoconstriction and Nitric Oxide-Mediated Relaxation Underlie Severe Pulmonary Hypertension in the Sugen-Hypoxia Rat Model.Remarkable Progress with Small-Molecule Modulation of TRPC1/4/5 Channels: Implications for Understanding the Channels in Health and Disease.The role of endothelial leak in pulmonary hypertension (2017 Grover Conference Series)Electrical Vagal Nerve Stimulation Ameliorates Pulmonary Vascular Remodeling and Improves Survival in Rats With Severe Pulmonary Arterial Hypertension
P2860
Q27310200-1142C121-08F9-4574-884D-059AB7A2A03DQ33788493-09FF623A-58CC-4419-84F4-A93B02FF36EDQ33804336-285B4B82-764F-4E69-A2AA-9A52D2D08B6FQ35016169-9205089A-672F-49B3-B8C7-F45825A22769Q37158233-F156FCC3-9727-4BC4-9446-45C59532C561Q37575862-9557F95A-3E06-46D8-8560-0EE06BB9861FQ38596162-E335D68E-64F7-435D-A376-F35EE77039ACQ41841126-07797497-18F2-4B16-8F09-881F3C940649Q42112003-865BE256-2197-4B74-9197-2A95392968BCQ46280838-6C612A52-E6AB-4990-9A72-E980EB7A4EFBQ46681971-F37130CF-B383-4175-8FB2-3B93AB438236Q49975721-2C7B2CEE-0233-4DDC-AE8A-3F62923CF342Q50046005-78A6E9D2-BC50-42A0-9E77-761009E10F32Q55476743-CC73FFDF-BA83-4632-A1E5-42F7670299C8Q58733559-2393453B-6F07-48BA-989C-8C05A4BB7B42Q59129600-521830D7-9537-401A-B94F-F052194CF354
P2860
TRPC4 inactivation confers a survival benefit in severe pulmonary arterial hypertension.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
TRPC4 inactivation confers a survival benefit in severe pulmonary arterial hypertension.
@en
TRPC4 inactivation confers a survival benefit in severe pulmonary arterial hypertension.
@nl
type
label
TRPC4 inactivation confers a survival benefit in severe pulmonary arterial hypertension.
@en
TRPC4 inactivation confers a survival benefit in severe pulmonary arterial hypertension.
@nl
prefLabel
TRPC4 inactivation confers a survival benefit in severe pulmonary arterial hypertension.
@en
TRPC4 inactivation confers a survival benefit in severe pulmonary arterial hypertension.
@nl
P2093
P2860
P1476
TRPC4 inactivation confers a survival benefit in severe pulmonary arterial hypertension.
@en
P2093
Ivan F McMurtry
Kealan O'Neill
Mark S Taylor
Masahiko Oka
Michael Francis
Michie Toba
Mikhail Alexeyev
Philip Almalouf
Troy Stevens
P2860
P304
P356
10.1016/J.AJPATH.2013.08.016
P407
P577
2013-10-08T00:00:00Z